These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11524469)

  • 21. Novel presenilin 1 mutations associated with early onset of dementia in a family with both early-onset and late-onset Alzheimer disease.
    Devi G; Fotiou A; Jyrinji D; Tycko B; DeArmand S; Rogaeva E; Song YQ; Medieros H; Liang Y; Orlacchio A; Williamson J; St George-Hyslop P; Mayeux R
    Arch Neurol; 2000 Oct; 57(10):1454-7. PubMed ID: 11030797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred.
    Pastor P; Roe CM; Villegas A; Bedoya G; Chakraverty S; García G; Tirado V; Norton J; Ríos S; Martínez M; Kosik KS; Lopera F; Goate AM
    Ann Neurol; 2003 Aug; 54(2):163-9. PubMed ID: 12891668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presenilins and early-onset familial Alzheimer's disease.
    Rohan de Silva HA; Patel AJ
    Neuroreport; 1997 May; 8(8):i-xii. PubMed ID: 9223053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel mutation of presenilin 1 in familial Alzheimer's disease in Israel detected by denaturing gradient gel electrophoresis.
    Reznik-Wolf H; Treves TA; Davidson M; Aharon-Peretz J; St George Hyslop PH; Chapman J; Korczyn AD; Goldman B; Friedman E
    Hum Genet; 1996 Dec; 98(6):700-2. PubMed ID: 8931704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic study of familial cases of Alzheimer's disease.
    Kowalska A; Pruchnik-Wolińska D; Florczak J; Modestowicz R; Szczech J; Kozubski W; Rossa G; Wender M
    Acta Biochim Pol; 2004; 51(1):245-52. PubMed ID: 15094846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the etiology of Alzheimer disease using molecular genetics.
    Lendon CL; Ashall F; Goate AM
    JAMA; 1997 Mar; 277(10):825-31. PubMed ID: 9052714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The genetics of Alzheimer disease and the application of molecular tests.
    Tobin SL; Chun N; Powell TM; McConnell LM
    Genet Test; 1999; 3(1):37-45. PubMed ID: 10464576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for presenilin-1 gene mutations by PCR-SSCP analysis in patients with early-onset Alzheimer's disease.
    Kowalska A; Florczak J; Pruchnik-Wolińska D; Hertmanowska H; Wender M
    Folia Neuropathol; 1998; 36(1):32-7. PubMed ID: 9595861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genetic counseling and testing for families with Alzheimer's disease].
    Kowalska A
    Neurol Neurochir Pol; 2004; 38(6):495-501. PubMed ID: 15654674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two novel presenilin 1 gene mutations connected with frontotemporal dementia-like clinical phenotype: genetic and bioinformatic assessment.
    Zekanowski C; Golan MP; Krzyśko KA; Lipczyńska-Łojkowska W; Filipek S; Kowalska A; Rossa G; Pepłońska B; Styczyńska M; Maruszak A; Religa D; Wender M; Kulczycki J; Barcikowska M; Kuźnicki J
    Exp Neurol; 2006 Jul; 200(1):82-8. PubMed ID: 16546171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel mutations and repeated findings of mutations in familial Alzheimer disease.
    Finckh U; Kuschel C; Anagnostouli M; Patsouris E; Pantes GV; Gatzonis S; Kapaki E; Davaki P; Lamszus K; Stavrou D; Gal A
    Neurogenetics; 2005 May; 6(2):85-9. PubMed ID: 15776278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.
    Gómez-Isla T; Growdon WB; McNamara MJ; Nochlin D; Bird TD; Arango JC; Lopera F; Kosik KS; Lantos PL; Cairns NJ; Hyman BT
    Brain; 1999 Sep; 122 ( Pt 9)():1709-19. PubMed ID: 10468510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presenilin-1 protein expression in familial and sporadic Alzheimer's disease.
    Levey AI; Heilman CJ; Lah JJ; Nash NR; Rees HD; Wakai M; Mirra SS; Rye DB; Nochlin D; Bird TD; Mufson EJ
    Ann Neurol; 1997 Jun; 41(6):742-53. PubMed ID: 9189035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The -48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased Abeta load in brain.
    Lambert JC; Mann DM; Harris JM; Chartier-Harlin MC; Cumming A; Coates J; Lemmon H; StClair D; Iwatsubo T; Lendon C
    J Med Genet; 2001 Jun; 38(6):353-5. PubMed ID: 11389157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
    Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
    PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease.
    Cruts M; van Duijn CM; Backhovens H; Van den Broeck M; Wehnert A; Serneels S; Sherrington R; Hutton M; Hardy J; St George-Hyslop PH; Hofman A; Van Broeckhoven C
    Hum Mol Genet; 1998 Jan; 7(1):43-51. PubMed ID: 9384602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular genetics of Alzheimer's disease--presenilin and other genes].
    Tabira T
    Rinsho Shinkeigaku; 1997 Dec; 37(12):1095-6. PubMed ID: 9577654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain.
    Lee J; Chan SL; Mattson MP
    Neuromolecular Med; 2002; 2(1):29-45. PubMed ID: 12230303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developmental expression of wild-type and mutant presenilin-1 in hippocampal neurons from transgenic mice: evidence for novel species-specific properties of human presenilin-1.
    Lévesque L; Annaert W; Craessaerts K; Mathews PM; Seeger M; Nixon RA; Van Leuven F; Gandy S; Westaway D; St George-Hyslop P; De Strooper B; Fraser PE
    Mol Med; 1999 Aug; 5(8):542-54. PubMed ID: 10501657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No association between the intronic presenilin-1 polymorphism and Alzheimer's disease in clinic and population-based samples.
    Cai X; Stanton J; Fallin D; Hoyne J; Duara R; Gold M; Sevush S; Scibelli P; Crawford F; Mullan M
    Am J Med Genet; 1997 Apr; 74(2):202-3. PubMed ID: 9129725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.